These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15198532)

  • 21. Effect of process parameters on nanoemulsion droplet size and distribution in SPG membrane emulsification.
    Oh DH; Balakrishnan P; Oh YK; Kim DD; Yong CS; Choi HG
    Int J Pharm; 2011 Feb; 404(1-2):191-7. PubMed ID: 21055456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased dissolution and physical stability of micronized nifedipine particles encapsulated with a biocompatible polymer and surfactants in a wet ball milling process.
    Li N; DeGennaro MD; Liebenberg W; Tiedt LR; Zahr AS; Pishko MV; de Villiers MM
    Pharmazie; 2006 Jul; 61(7):595-603. PubMed ID: 16889066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phospholipid-stabilized Au-nanoparticles.
    He P; Urban MW
    Biomacromolecules; 2005; 6(3):1224-5. PubMed ID: 15877336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anion effects on electrostatic charging of sterically stabilized, water insoluble drug particles.
    Owen H; Graham S; Werling JO; Carter PW
    Int J Pharm; 2009 Feb; 368(1-2):154-9. PubMed ID: 18996460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions.
    Li P; Ghosh A; Wagner RF; Krill S; Joshi YM; Serajuddin AT
    Int J Pharm; 2005 Jan; 288(1):27-34. PubMed ID: 15607255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, characterization and in vivo assessment of the bioavailability of glycyrrhizic acid microparticles by supercritical anti-solvent process.
    Sui X; Wei W; Yang L; Zu Y; Zhao C; Zhang L; Yang F; Zhang Z
    Int J Pharm; 2012 Feb; 423(2):471-9. PubMed ID: 22183131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of cyclosporine-loaded poly-sigma-caprolactone nanoparticles.
    Molpeceres J; Aberturas MR; Chacón M; Berges L; Guzmán M
    J Microencapsul; 1997; 14(6):777-87. PubMed ID: 9394259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
    Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
    Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel preparation of solid lipid nanoparticles with cyclosporin A for prolonged drug release.
    Hu FQ; Wu MZh; Yuan H; Zhang HH
    Pharmazie; 2004 Sep; 59(9):683-5. PubMed ID: 15497749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of nano/micro-dispersions with improved dissolution properties upon dispersion of ritonavir melt extrudate in aqueous media.
    Tho I; Liepold B; Rosenberg J; Maegerlein M; Brandl M; Fricker G
    Eur J Pharm Sci; 2010 Apr; 40(1):25-32. PubMed ID: 20172027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
    Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
    J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of polymeric nanoparticles of cyclosporin A using infrared pulsed laser.
    Takebe G; Takagi T; Suzuki M; Hiramatsu M
    Int J Pharm; 2011 Jul; 414(1-2):244-50. PubMed ID: 21596126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creation of highly stable selenium nanoparticles capped with hyperbranched polysaccharide in water.
    Zhang Y; Wang J; Zhang L
    Langmuir; 2010 Nov; 26(22):17617-23. PubMed ID: 20964304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
    Park J; Park HJ; Cho W; Cha KH; Kang YS; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):239-45. PubMed ID: 20599602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and pharmacokinetics of coenzyme Q10 nanoparticles prepared by a rapid expansion of supercritical solution process.
    Meng X; Zu Y; Zhao X; Li Q; Jiang S; Sang M
    Pharmazie; 2012 Feb; 67(2):161-7. PubMed ID: 22512087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel strategy to produce highly stable and transparent aqueous 'nanosolutions' of water-insoluble drug molecules.
    Wang JX; Zhang ZB; Le Y; Zhao H; Chen JF
    Nanotechnology; 2011 Jul; 22(30):305101. PubMed ID: 21705830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical size of crystalline ZrO(2) nanoparticles synthesized in near- and supercritical water and supercritical isopropyl alcohol.
    Becker J; Hald P; Bremholm M; Pedersen JS; Chevallier J; Iversen SB; Iversen BB
    ACS Nano; 2008 May; 2(5):1058-68. PubMed ID: 19206504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A salt-free zero-charged aqueous onion-phase enhances the solubility of fullerene C60 in water.
    Li H; Jia X; Li Y; Shi X; Hao J
    J Phys Chem B; 2006 Jan; 110(1):68-74. PubMed ID: 16471501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS; Jin SJ; Kim JS; Park HJ; Song HS; Neubert RH; Hwang SJ
    Eur J Pharm Biopharm; 2008 Jun; 69(2):454-65. PubMed ID: 18359211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.